Asset Management One Trims Stake in HCA Healthcare

The investment firm reduced its holdings in the healthcare provider by 3.2% in Q4 2025.

Apr. 19, 2026 at 7:30am

An extreme close-up of industrial machinery and financial instruments, conveying the institutional and technical nature of asset management decisions without using literal currency or charts.A reduction in institutional ownership of HCA Healthcare shares suggests a more cautious market outlook on the healthcare provider's near-term performance.Today in Nashville

Asset Management One Co. Ltd. lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 72,744 shares of the company's stock after selling 2,436 shares during the period.

Why it matters

HCA Healthcare is one of the largest for-profit hospital operators in the United States, with a network of acute care facilities, surgical centers, and outpatient clinics. Changes in institutional ownership of the company's stock can signal shifts in investor sentiment and market expectations.

The details

Asset Management One Co. Ltd. reported owning 72,744 shares of HCA Healthcare stock at the end of the fourth quarter, down from 75,180 shares held at the end of the prior quarter. The firm's position represented a 3.2% reduction in its HCA Healthcare holdings during the three-month period.

  • Asset Management One Co. Ltd. filed its 13F report for the fourth quarter of 2025 on April 19, 2026.
  • The firm reduced its HCA Healthcare stake during the three-month period ending December 31, 2025.

The players

Asset Management One Co. Ltd.

An investment management firm based in Japan that reported owning shares of HCA Healthcare as of the end of 2025.

HCA Healthcare, Inc.

A for-profit operator of acute care hospitals, surgical centers, and outpatient clinics headquartered in Nashville, Tennessee.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Asset Management One's HCA Healthcare position suggests the firm may have a more cautious outlook on the healthcare provider's near-term prospects, though the overall investment thesis remains positive as indicated by the firm's continued sizable stake in the company.